Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Clinical trial NCT06926751 · RECRUITING

Trial details

NCT number: NCT06926751
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors Children Adolescent Chemotherapy Induced Neutropenia

Start date: 2025-06-12
Primary completion: 2027-04-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.